Bradley L. Campbell
President and CEO · AMICUS THERAPEUTICS, INC.
- 2024
- Apr 27, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bradley L. Campbell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Michael Clark - $1.15M in FOLD purchases and sales in the last 12 months
- Ellen Rosenberg - $958K in FOLD purchases and sales in the last 12 months
- Jeff Castelli - $774K in FOLD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bradley L. Campbell?
Bradley L. Campbell is a corporate insider, tracked as President and CEO of AMICUS THERAPEUTICS, INC. (FOLD). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Bradley L. Campbell last file a Form 4?
The most recent primary Form 4 on record is dated 27 April 2026, one of 11 filings going back to 2024.
Has Bradley L. Campbell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($2.87M) across all tracked filings.
